dual laser

Acorda Therapeutics, Inc. (Nasdaq: ACOR) 49.9% HIGHER; announced the FDA eripheral and Central Nervous System Drugs Advisory Committee voted 12 to 1 that clinical data on Fampridine-SR 10 mg twice daily demonstrated substantial evidence of effectiveness as a treatment to improve walking in people with multiple sclerosis (MS) and voted 10 to 2 (1 abstention) that it is clinically meaningful and can be safe for use. Click here for the full report.

Solta Medical, Inc. (NASDAQ: SLTM) 46% HIGHER; today announced it has received FDA 510(k) clearance for the new Fraxel re:store Dual laser system.

The Fraxel re:store Dual system takes the industry leading fractional laser technology to the next level by adding a novel 1927 nm wavelength, the first ever application of a Thulium laser in the aesthetics market. Click here for the full report.

Rubio's(R) Restaurants, Inc.